Radiotherapy-induced cell death activates paracrine HMGB1-TLR2 signaling and accelerates pancreatic carcinoma metastasis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Radiotherapy-induced cell death activates paracrine HMGB1-TLR2 signaling and accelerates pancreatic carcinoma metastasis ; volume:37 ; number:1 ; day:3 ; month:4 ; year:2018 ; pages:1-15 ; date:12.2018
Journal of experimental & clinical cancer research ; 37, Heft 1 (3.4.2018), 1-15, 12.2018
- Urheber
-
Chen, Xuelian
- Beteiligte Personen und Organisationen
-
Zhang, Lirong
Jiang, Yujie
Song, Lian
Liu, Yanfang
Cheng, Fang
Fan, Xin
Cao, Xiongfeng
Gong, Aihua
Wang, Dongqing
Zhu, Haitao
SpringerLink (Online service)
- DOI
-
10.1186/s13046-018-0726-2
- URN
-
urn:nbn:de:101:1-2018060921525151094483
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Xuelian
- Zhang, Lirong
- Jiang, Yujie
- Song, Lian
- Liu, Yanfang
- Cheng, Fang
- Fan, Xin
- Cao, Xiongfeng
- Gong, Aihua
- Wang, Dongqing
- Zhu, Haitao
- SpringerLink (Online service)
Ähnliche Objekte (12)
HMGB1 released by irradiated tumor cells promotes living tumor cell proliferation via paracrine effect
Aggravated renal fibrosis is positively associated with the activation of HMGB1-TLR2/4 signaling in STZ-induced diabetic mice
V1bR enhances glucose-stimulated insulin secretion by paracrine production of glucagon which activates GLP-1 receptor
Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation
Ligation of free HMGB1 to TLR2 in the absence of ligand is negatively regulated by the C-terminal tail domain
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Targeting microglial TLR2 in glioma therapy
Paracrine humanin signaling promotes glioma chemoresistance
Phenotypic diversity drives paracrine drug tolerance
HMGB1 in inflammation and cancer
HMGB1, neuronal excitability and epilepsy
Identification of a TLR2 Inhibiting Wheat Hydrolysate
HMGB1 released by irradiated tumor cells promotes living tumor cell proliferation via paracrine effect
Aggravated renal fibrosis is positively associated with the activation of HMGB1-TLR2/4 signaling in STZ-induced diabetic mice
V1bR enhances glucose-stimulated insulin secretion by paracrine production of glucagon which activates GLP-1 receptor
Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation
Ligation of free HMGB1 to TLR2 in the absence of ligand is negatively regulated by the C-terminal tail domain
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Targeting microglial TLR2 in glioma therapy
Paracrine humanin signaling promotes glioma chemoresistance
Phenotypic diversity drives paracrine drug tolerance
HMGB1 in inflammation and cancer
HMGB1, neuronal excitability and epilepsy
Identification of a TLR2 Inhibiting Wheat Hydrolysate
HMGB1 released by irradiated tumor cells promotes living tumor cell proliferation via paracrine effect
Aggravated renal fibrosis is positively associated with the activation of HMGB1-TLR2/4 signaling in STZ-induced diabetic mice
V1bR enhances glucose-stimulated insulin secretion by paracrine production of glucagon which activates GLP-1 receptor
Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation
Ligation of free HMGB1 to TLR2 in the absence of ligand is negatively regulated by the C-terminal tail domain
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Targeting microglial TLR2 in glioma therapy
Paracrine humanin signaling promotes glioma chemoresistance
Phenotypic diversity drives paracrine drug tolerance
HMGB1 in inflammation and cancer
HMGB1, neuronal excitability and epilepsy